AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Report summarizes fibrosis study findings from K.J.H. Sparbel and co-researchers.
According to a study from the United States, "Cystic fibrosis carrier testing (CFCT) is among the first of the DNA tests offered prenatally in primary care settings. This paper from a descriptive qualitative study describes the influence of pregnancy in CFCT decisions by women receiving community-based prenatal care."
"Twenty-seven women receiving prenatal care in Midwestern U. S. primary care clinics completed semistructured interviews. Audiotaped interviews were analyzed using content analysis. Participants described decision-making influences and strategies from the perspective of ''being pregnant.'' Patterns of attitudes and beliefs include (1) dealing with emotions, (2) pregnancy is natural, and (3) thinking about the baby. Strategies in the decision-making process included (1) reducing stress, (2) choosing what is relevant, (3) doing everything right, (4) wanting to be prepared, (5) delaying information, and (6) trusting God. While other factors were mentioned by some women, major themes reflect the influence of currently being pregnant on the decision-making process. These findings suggest that pregnancy is a powerful influence on the decision-making process and may not be the optimal time ...
- Research and Markets: Molecular Biomarkers for Clinical Diagnostics and Drug...
- Press release article from: Business Wire September 16, 2004 700+ words
...The Worldwide Market Size for Molecular Biomarkers, Diagnostics and Related Molecular...has announced the addition of Molecular Biomarkers for Clinical Diagnostics and Drug...This report is about the market for molecular biomarkers for clinical diagnostics and for...
- Publication No. WO/2009/126232 Published on Oct. 15, Assigned to BLANCHETTE...
- News wire article from: US Fed News Service, Including US State News October 16, 2009 700+ words
...ALZHEIMER'S DISEASE-SPECIFIC MOLECULAR BIOMARKERS (ADSMB). The patent has been...Alzheimer's Disease- specific molecular biomarkers disclosed herein are useful for...Alzheimer's Disease-specific molecular biomarkers disclosed herein". The invention...
- Molecular Biomarkers Predicting Efficacy of Introgen Therapeutics' ADVEXIN...
- Press release article from: PR Newswire September 15, 2006 700+ words
...reached agreement with the U.S. Food and Drug Administration (FDA) to incorporate the use of Introgen's p53 molecular biomarkers in the analysis of ADVEXIN clinical data used in support of FDA submissions for approval. Data were presented...
- Molecular biomarkers predicting efficacy of cancer therapy highlighted.
- Newspaper article from: BIOTECH Patent News September 1, 2006 700+ words
...agreement with the United States Food and Drug Administration (FDA) to incorporate the use of Introgen's p53 molecular biomarkers in the analysis of ADVEXIN clinical data used in support of FDA submissions for approval. Data were presented...
- Scientists: New Technique Identifies Molecular 'Biomarkers' for Disease.
- News wire article from: Ascribe Higher Education News Service March 31, 2008 700+ words
Byline: University of Florida GAINESVILLE, Fla., March 31 (AScribe Newswire) -- University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases -- without any previous knowledge of what these microscopic signatures or "biomarkers" should look
- AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves...
- Press release article from: PR Newswire May 13, 2008 700+ words
-Specific biomarkers for molecular tumor grade and endocrine benefit offer better prediction of individual patient outcome- SAN DIEGO, May 13 /PRNewswire/ -- AviaraDx, Inc. today announced the publication of an article describing the discovery, development and validation of a new molecular
- Siemens and Subsidiary PETNET Pharmaceuticals, Inc. Acquire PETNET...
- Press release article from: Business Wire February 27, 2006 700+ words
MALVERN, Pa. & WOBURN, Mass. -- Siemens Medical Solutions with its subsidiary PETNET(R) Pharmaceuticals, Inc. announced today it has acquired full ownership of New England PETNET Manufacturing & Distribution Center, LLC in Woburn, Mass. The acquisition, a result of continuing efforts of
- SeraCare Launches Genetic Testing Controls Business Line.
- Press release article from: Business Wire October 30, 2008 700+ words
...additional controls for genetic testing, including screening for...warfarin should undergo genetic testing prior to long term use...synthetic controls for genetic testing for cystic fibrosis and...derived reagents and molecular biomarkers, biobanking and contract...
Source: HighBeam Research, Report summarizes fibrosis study findings from K.J.H. Sparbel and...